Literature DB >> 27397482

Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC).

Michele Aieta1, Antonella Facchinetti2, Stefania De Faveri3, Mariangela Manicone3, Alfredo Tartarone1, Luciana Possidente4, Rosa Lerose5, Giuseppina Mambella1, Giuseppe Calderone1, Rita Zamarchi6, Elisabetta Rossi2.   

Abstract

Entities:  

Keywords:  Circulating tumor cells (CTCs); Crizotinib; Drug resistance; EML4-ALK; Liquid biopsy

Mesh：

Substances：

Year:  2016        PMID： 27397482     DOI： 10.1016/j.cllc.2016.05.002

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  16 in total

Review 1.  Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer.

Authors:  Mariangela Manicone; Cristina Poggiana; Antonella Facchinetti; Rita Zamarchi
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 2.  Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.

Authors:  Alfredo Tartarone; Rosa Lerose; Maria Grazia Rodriquenz; Giuseppina Mambella; Giuseppe Calderoni; Giovanni Bozza; Michele Aieta
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 3.  Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared.

Authors:  Mariangela Manicone; Maria Chiara Scaini; Maria Grazia Rodriquenz; Antonella Facchinetti; Alfredo Tartarone; Michele Aieta; Rita Zamarchi; Elisabetta Rossi
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 4.  Blood-based tumor biomarkers in lung cancer for detection and treatment.

Authors:  Hirva Mamdani; Shahid Ahmed; Samantha Armstrong; Tony Mok; Shadia I Jalal
Journal:  Transl Lung Cancer Res       Date:  2017-12

5.  Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor.

Authors:  Paolo Bonvini; Elisabetta Rossi; Angelica Zin; Mariangela Manicone; Riccardo Vidotto; Antonella Facchinetti; Lucia Tombolan; Maria Carmen Affinita; Luisa Santoro; Rita Zamarchi; Gianni Bisogno
Journal:  Front Pediatr       Date:  2021-04-29       Impact factor: 3.418

Review 6.  Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration.

Authors:  Lei Wang; Coraline Dumenil; Catherine Julié; Violaine Giraud; Jennifer Dumoulin; Sylvie Labrune; Thierry Chinet; Jean-François Emile; Biao He; Etienne Giroux Leprieur
Journal:  Oncotarget       Date:  2017-11-23

Review 7.  The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor.

Authors:  Yating Chen; Wenjie Guo; Junsheng Fan; Yuqing Chen; Xiaoli Zhang; Xin Chen; Peng Luo
Journal:  Cancer Manag Res       Date:  2017-12-07       Impact factor: 3.989

Review 8.  ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2017-08-12       Impact factor: 6.639

Review 9.  The liquid biopsy in lung cancer.

Authors:  Junaid Ansari; Jungmi W Yun; Anvesh R Kompelli; Youmna E Moufarrej; Jonathan S Alexander; Guillermo A Herrera; Rodney E Shackelford
Journal:  Genes Cancer       Date:  2016-11

10.  Correlation between the presence of circulating tumor cells and the pathologic type and staging of non-small cell lung cancer during the early postoperative period.

Authors:  Zhanqiang Xie; Xiaotian Gao; Keluo Cheng; Lishuang Yu
Journal:  Oncol Lett       Date:  2017-09-07       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.